此次符合条件的东北制药股东将享有公司自有"栖芳源"系列化妆品"买1得4"+专享9折双重福利。股东专 享9折优惠券可在"买1得4"优惠基础上叠加使用，即先享受"买1得4"的组合权益，再对组合产品的结算 金额打9折。 中证报中证网讯（记者 宋维东）12月23日晚，东北制药（000597）公告称，公司拟开展股东回馈活 动，更好地帮助股东了解公司新投放市场的"栖芳源紧致焕颜精粹水""栖芳源紧致焕颜面膜""栖芳源水 光深润倍护面膜"等自有美妆品牌产品，体验多重功效，向股东展示公司在大健康领域布局的最新成 果；同时，建立长效、多样的股东回报机制，提高股东对公司内在价值的理解与认识。 根据安排，本次活动时间为2025年12月25日00:00:00至2025年12月28日23:59:59。参加活动股东的范围 为2025年12月8日下午收市时在中国证券登记结算有限责任公司深圳分公司登记在册的持有东北制药股 份500股（含）以上的股东。公司将在活动期间内不定期主动更新股东信息，未在前述股东名册中的现 有持股股东，亦可通过有效的股东持股证明文件享有本次活动权益。 此外，东北制药充分利用在研发及品控管理方面积累的丰富经验，拓展药食同 ...

Core Viewpoint - Northeast Pharmaceutical is focusing on market trends, leveraging its two core sales segments, raw materials and formulations, to achieve significant results and ensure stable performance for the company [1] Raw Material Segment - Northeast Pharmaceutical is a key global supplier of raw materials, enhancing its international market competitiveness, particularly in the EU and Japan/Korea, with market share increasing year by year [2] - The raw material sales company demonstrated strong market capabilities in Q4, with profits exceeding planned targets for two consecutive months in October and November, particularly in November [2] - Key products such as Vitamin C and L-Carnitine exceeded sales targets, while other products like Amantadine and Piracetam also performed well, enhancing the product matrix's competitiveness [2] - The company actively participated in major industry exhibitions to connect with core customer needs and adjust market strategies based on competitor insights [2][3] Formulation Segment - Northeast Pharmaceutical's formulation products rank first in domestic sales, contributing to economic benefits and enhancing brand recognition [4] - The formulation sales company is focusing on maintaining and expanding the market competitiveness of key products, with systematic planning for products like Gut Health and Pain Relief tablets [4] - Efficient execution and collaboration among teams have led to achieving monthly performance targets, providing confidence for year-end goals [4][5] Expansion into New Fields - In Q4, Northeast Pharmaceutical made significant strides in the health sector by launching new products such as health biscuits and advancing the development of additional health-oriented snacks [6] - The company is exploring the beauty sector with functional skincare products, leveraging its pharmaceutical-grade standards in product development [6] - The company aims to optimize its health product matrix and explore comprehensive health services, creating new growth points [6]

Core Insights - The company is focusing on market trends, with its two core sales segments, raw materials and formulations, playing a significant role in stabilizing performance and achieving important results in market penetration [1][2] - The company is actively expanding in the health sector, launching new products that contribute to comprehensive health services, providing confidence and direction for future work [1][4] Raw Material Segment - The company is a key global supplier of raw materials, enhancing its international market competitiveness, particularly in the EU and Japan, with market share increasing year by year [1][2] - In Q4, the raw material sales company demonstrated strong market capabilities, exceeding profit targets in October and November, with notable performance in November [1][2] - Key products such as Vitamin C and L-Carnitine significantly outperformed sales targets, indicating a strengthening product matrix [1][2] Market Expansion and Management - The raw material sales company has actively participated in major industry exhibitions to engage with core customers and align market orders, while also monitoring industry trends and competitor dynamics [2] - Internal management has been enhanced, with a focus on accountability and improving business capabilities, leading to effective collaboration across departments [2] Formulation Segment - The company has several formulation products that rank first in domestic sales, contributing to economic benefits and enhancing brand recognition [3] - A systematic approach has been adopted to boost sales of key products, with effective execution leading to monthly performance improvements [3] New Product Development - In Q4, the company made significant strides in the health sector by launching new products such as health-oriented biscuits, while also developing additional products to meet diverse health needs [4] - The company is leveraging its experience in R&D and quality control to explore the health food sector, including functional skincare products that integrate pharmaceutical technology [4][5] Strategic Focus - The company aims to leverage its comprehensive advantages in innovation, resource allocation, and market positioning to optimize its health product matrix and explore new growth points in the health sector [5]

Core Insights - Northeast Pharmaceutical, a subsidiary of Liaoning Fangda Group, is focusing on expanding its business in the pharmaceutical and health sectors through three key initiatives: drug research and innovation, development of health food products, and entry into the beauty industry with functional skincare products [2][3]. Group 1: Pharmaceutical Innovation - The company views research and innovation as its "lifeline" and has established a robust R&D system, successfully launching over 20 new raw materials and formulations in recent years [3]. - The recent approval of the DC-TY0801 injection for clinical trials marks a significant advancement in the company's oncology treatment portfolio, specifically targeting EGFRvIII positive recurrent or progressive high-grade glioma [3]. - The company is also expanding its pipeline with multiple tumor-targeted cell therapy products, enhancing its capabilities in the healthcare service sector [3]. Group 2: Health Food Development - Northeast Pharmaceutical is tapping into the health food market by launching a series of health-oriented biscuits, including products made from traditional Chinese medicinal ingredients [4]. - The biscuits are developed in collaboration with local universities, ensuring adherence to national food safety standards and scientific formulation [4][5]. - The product line includes various flavors designed to meet different health needs, showcasing the integration of traditional health concepts with modern food technology [4][5]. Group 3: Expansion into Beauty Industry - The company has launched a functional skincare brand, "Qifangyuan," which combines pharmaceutical standards with skincare innovation [6]. - The skincare products are developed using pharmaceutical-grade raw materials and undergo rigorous safety and efficacy testing [6]. - This move is part of a broader strategy to diversify and meet the growing demand for comprehensive health services, leveraging the company's expertise in pharmaceuticals [6].